---
figid: PMC5394116__fonc-07-00064-g001
figlink: /pmc/articles/PMC5394116/figure/F1/
number: F1
caption: 'Although a myriad of intracellular signaling is involved in passive therapies,
  their pathways show some overlap. In this figure, the checkpoint receptors PD-1
  and CTLA4 are both shown to activate SHP2 leading to inhibition of microcluster
  signaling molecules, indirectly opposing the actions of activated stimulatory receptor
  CD28; checkpoint blockade prevents T-cell inhibition in this regard. Small molecule
  targets such as CXCR5, CCR5, and TKR are all also shown to converge with the checkpoint
  inhibitor MOA at the PI3K/Akt survival pathway, some through inhibition or some
  through activation depending on whether these effects are seen in Treg or Teff.
  Intermediaries such as JNK and Ras are seen with CCR5 and TKR, respectively. Downstream
  of all pathways is the activation or inhibition of caspase-mediated apoptosis. Abbreviations:
  CCR5, C-C chemokine receptor type 5; CTLA4, cytotoxic T-lymphocyte-associated protein
  4; CXCR4, C-X-C chemokine receptor type 4; JNK, c-Jun N-terminal kinase; mTOR, mechanistic
  target of rapamycin; PD-1, programmed cell death protein 1; PI3K, phosphatidylinositol-3-kinases;
  PP2A, protein phosphatase 2a; TKR, tyrosine kinase receptor. Some elements adapted
  from Servier Medical Art (https://creativecommons.org/licenses/by/3.0/legalcode).'
pmcid: PMC5394116
papertitle: Advancing Cancer Therapy with Present and Emerging Immuno-Oncology Approaches.
reftext: Jeff Kamta, et al. Front Oncol. 2017;7:64.
pmc_ranked_result_index: '74962'
pathway_score: 0.9629375
filename: fonc-07-00064-g001.jpg
figtitle: Although a myriad of intracellular signaling is involved in passive therapies,
  their pathways show some overlap
year: '2017'
organisms: Homo sapiens
ndex: 480e0139-deb7-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5394116__fonc-07-00064-g001.html
  '@type': Dataset
  description: 'Although a myriad of intracellular signaling is involved in passive
    therapies, their pathways show some overlap. In this figure, the checkpoint receptors
    PD-1 and CTLA4 are both shown to activate SHP2 leading to inhibition of microcluster
    signaling molecules, indirectly opposing the actions of activated stimulatory
    receptor CD28; checkpoint blockade prevents T-cell inhibition in this regard.
    Small molecule targets such as CXCR5, CCR5, and TKR are all also shown to converge
    with the checkpoint inhibitor MOA at the PI3K/Akt survival pathway, some through
    inhibition or some through activation depending on whether these effects are seen
    in Treg or Teff. Intermediaries such as JNK and Ras are seen with CCR5 and TKR,
    respectively. Downstream of all pathways is the activation or inhibition of caspase-mediated
    apoptosis. Abbreviations: CCR5, C-C chemokine receptor type 5; CTLA4, cytotoxic
    T-lymphocyte-associated protein 4; CXCR4, C-X-C chemokine receptor type 4; JNK,
    c-Jun N-terminal kinase; mTOR, mechanistic target of rapamycin; PD-1, programmed
    cell death protein 1; PI3K, phosphatidylinositol-3-kinases; PP2A, protein phosphatase
    2a; TKR, tyrosine kinase receptor. Some elements adapted from Servier Medical
    Art (https://creativecommons.org/licenses/by/3.0/legalcode).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3R4
  - PIK3CB
  - PIK3R5
  - PIK3CA
  - CASP3
  - CASP12
  - AKT2
  - PIK3R6
  - CASP7
  - AKT1
  - MTOR
  - PDCD1
  - CASP10
  - MAPK10
  - AKT3
  - CASP14
  - PIK3CD
  - MAPK9
  - MAPK8
  - CTLA4
  - CASP6
  - CASP1
  - PIK3CG
  - CASP8
  - CASP9
  - HRAS
  - KRAS
  - CD28
  - PIK3R3
  - TKTL1
  - CASP5
  - NRAS
  - PTPN11
  - CASP4
  - CXCR4
  - CASP2
  - Cancer
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PD-1
  symbol: PD-1
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1
  entrez: '5133'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: CTLA4
  symbol: CTLA4
  source: hgnc_symbol
  hgnc_symbol: CTLA4
  entrez: '1493'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: CD28
  symbol: CD28
  source: hgnc_symbol
  hgnc_symbol: CD28
  entrez: '940'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: TKR
  symbol: TKR
  source: hgnc_alias_symbol
  hgnc_symbol: TKTL1
  entrez: '8277'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: SHP-2
  symbol: SHP-2
  source: hgnc_alias_symbol
  hgnc_symbol: PTPN11
  entrez: '5781'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: CXCR4
  symbol: CXCR4
  source: hgnc_symbol
  hgnc_symbol: CXCR4
  entrez: '7852'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC5394116__F1
redirect_from: /figures/PMC5394116__F1
figtype: Figure
---
